PCR Fluorescence
-
Ụdị ọrịa poliovirus bụ ọrịa na-efe efe
Ngwa a dabara adaba maka ịchọpụta qualitative nke ụdị poliovirus I nucleic acid na stool samples in vitro.
-
Ụdị Poliovirus Ⅱ
Ngwa a dabara adaba maka nchọpụta qualitative nke ụdị Poliovirus Ⅱnucleic acid na stool samples in vitro.
-
Enterovirus 71 (EV71)
Ezubere ngwa a maka nchọpụta qualitative in vitro nke enterovirus 71 (EV71) nucleic acid na oropharyngeal swabs na ihe nlele mmiri herpes nke ndị ọrịa nwere ọrịa ọnụ ụkwụ.
-
Enterovirus Universal
Emebere ngwaahịa a maka nchọpụta qualitative in vitro nke enteroviruses na swabs oropharyngeal na ihe nlele mmiri mmiri herpes. Ngwa a bụ maka enyemaka iji chọpụta ọrịa ọnụ ụkwụ aka.
-
Ụdị nje virus nke Herpes Simplex 1
A na-eji ngwa a maka nchọpụta qualitative nke Herpes Simplex Virus Type 1 (HSV1).
-
Chlamydia trachomatis, Neisseria Gonorrhea na Trichomonas vaginalis.
Ezubere ngwa a maka nchọpụta in vitro qualitative chlamydia trachomatis (CT), Neisseria gonorrheae (NG)naTrichomonal vaginitis (TV) na nwoke urethra swab, nwanyi cervical swab, na nwanyi swab samples, na-enye aka na nchoputa na ọgwụgwọ nke ndị ọrịa nwere genitourinary tract ọrịa.
-
Trichomonas vaginalis nucleic acid
A na-eji ngwa a maka nchọpụta qualitative nke Trichomonas vaginalis nucleic acid na ihe nleba anya nzuzo urogenital mmadụ.
-
Ejikọtara Ọrịa iku ume
A na-eji ngwa a maka nchọpụta qualitative nke ọrịa na-eku ume na nucleic acid ewepụtara n'ụdị swab oropharyngeal mmadụ.
A na-eji ihe atụ a maka nchọpụta qualitative nke 2019-nCoV, nje influenza A, nje influenza B na nje virus syncytial nucleic acid n'ụdị mmadụ oropharyngeal swab sample.
-
Ejikọtara Ọrịa iku ume
A na-eji ngwa a maka nchọpụta qualitative in vitro nke nje influenza A, nje influenza B, nje syncytial iku ume, adenovirus, rhinovirus mmadụ na mycoplasma pneumoniae nucleic acids na mmadụ nasopharyngeal swabs na oropharyngeal swab samples. Enwere ike iji nsonaazụ ule ahụ mee ihe maka enyemaka maka nyocha nke ọrịa nje na-efe efe nke iku ume, ma na-enye ihe ndabere nchọpụta mkpụrụ ndụ ihe enyemaka maka nyocha na ọgwụgwọ nke ọrịa nje iku ume.
-
Ụdị 14 dị iche iche nke genitourinary tract ọrịa ọrịa
Ezubere ngwa ahụ maka nchọpụta in vitro qualitative chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus ụdị 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus ụdị 2 (HSV2), Mycoplasma (Ureaplasma Hominis), Ureaplasma urealyticum (UU), Herpes simplex virus ụdị 2 (HSV2), Ureaplasma (Ureaplasma). Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), na Treponema pallidum (TP) na mmamịrị, nwoke urethral swab, nwanyị cervical swab, na nwanyị na-arịa ọrịa na-ahụ maka ikpu, na-enye ọgwụgwọ nchoputa na ọgwụgwọ swab ọrịa traktị.
-
SARS-CoV-2/influenza A/influenza B
Nke a kit bụ adabara in vitro qualitative nchọpụta nke SARS-CoV-2, influenza A na influenza B nucleic acid nke nasopharyngeal swab na oropharyngeal swab samples nke ndị mmadụ na-enyo enyo na ọ bụ ọrịa nke SARS-CoV-2, influenza A na influenza B. Ọ nwekwara ike iji na-enyo enyo na pflumoniit ikpe na p. mata SARS-CoV-2, influenza A na influenza B nucleic acid na nasopharyngeal swab na oropharyngeal swab sample nke novel Coronavirus ọrịa n'ọnọdụ ndị ọzọ.
-
Ụdị 18 nke Nje Virus Nucleic Acid Papilloma nke mmadụ nwere nnukwu ihe ize ndụ
Ngwa a dabara adaba maka nchọpụta qualitative in vitro nke ụdị 18 nke nje papilloma mmadụ (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 38, 8 g) nucleic acid. mmamịrị nwoke/nwoke na nwanyị cervical exfoliated cell na HPV 16/18 dee.
